Chinese cancer screening firm New Horizon Health said to pick banks for IPO

Chinese cancer screening firm New Horizon Health said to pick banks for IPO

New Horizon Health Ltd., a Chinese maker of home test kits for colon cancer, has picked Goldman Sachs Group Inc. and UBS Group AG to arrange its planned initial public offering in Hong Kong, according to people familiar with the matter.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter